FDA Becomes An Agency Of “Directorates” Under Hamburg’s Reorganization

Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the agency’s centers intact, but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.